Akhila Menon
About Akhila Menon
Akhila Menon is a Manager at Safety Gateway for Bristol Myers Squibb and a Drug Safety Specialist at Celgene, with over a decade of experience in pharmacovigilance.
Current Roles at Bristol Myers Squibb and Celgene
Akhila Menon currently holds the position of Manager, Safety Gateway at Bristol Myers Squibb, a role she has been fulfilling since March 2022. She also serves as a Drug Safety Specialist at Celgene, based in Summit, New Jersey. Her dual roles encompass managing and overseeing safety protocols and drug safety regulations, reflecting her comprehensive expertise in the pharmacovigilance field.
Previous Experience in Pharmacovigilance
Akhila Menon has a decade of experience in pharmacovigilance and regulatory affairs, having worked with multiple leading pharmaceutical companies. She spent 11 months at Biogen Idec as a Senior Safety Associate and 5 months as a Safety and Benefit Risk Management Co-op. Prior to that, she was a Drug Safety Associate at Tata Consultancy Services for a year and interned at Flamingo Pharmaceuticals Ltd. Her roles involved tasks such as safety case management and benefit-risk assessments.
Educational Background in Regulatory Affairs and Pharmacy
Akhila Menon pursued her Master's degree in Regulatory Affairs in Drugs, Biologics, and Medical Devices from Northeastern University, completing her studies in December 2015. She holds a Bachelor's degree in Pharmacy from Bharati Vidyapeeth's Institute of Pharmacy, where she studied from 2008 to 2012. Her academic background provides a strong foundation in drug safety and regulatory compliance.
Experience in U.S. and Indian Pharmaceutical Industries
Throughout her career, Akhila Menon has accumulated experience in both the U.S. and Indian pharmaceutical industries. Her positions in the Greater Boston Area and Mumbai have equipped her with a diverse perspective on global drug safety standards and practices. This international exposure is a significant asset in her current role, ensuring compliance with safety requirements across different regulatory environments.